NRC Health (NRC) stock

NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3081% above fair value

$26.56−0.08 (-0.30%)

Close on Nov 13, 2026Market cap $587.50MP/E –Yield 1.96%

NRC Health EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

NRC Health's EV/EBITDA was 29.2× on Nov 11, 2026, against 13.3× a year earlier. Over the last 5 years it ranged from 7.7× to 29.2×, with a median of 18.6×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	29.2×	+14.7
2025	Dec 31, 2025	14.5×	+3.9
2024	Dec 31, 2024	10.5×	−13.7
2023	Dec 29, 2023	24.2×	+4.9
2022	Dec 30, 2022	19.3×	−2.3
2021	Dec 31, 2021	21.6×	−0.0
2020	Dec 31, 2020	21.6×	−14.4
2019	Dec 31, 2019	36.0×	+11.6
2018	Dec 31, 2018	24.5×	+20.4
2013	Jul 31, 2013	4.1×	−1.9
2012	Dec 31, 2012	5.9×	−2.6
2011	Dec 30, 2011	8.5×	−1.0
2010	Dec 31, 2010	9.5×	–